National Cancer Institute, DCCPS, Surveillance Research Program. (2020). Surveillance, Epidemiology, and End Results Program: SEER Cancer Stat Facts: Childhood leukemia (ages 0–19). https://seer.cancer.gov/statfacts/html/childleuk.html. Accessed 14 Feb 2024.

Bhojwani, D., & Pui, C.-H. (2013). Relapsed childhood acute lymphoblastic leukaemia. The Lancet Oncology, 14(6), e205–e217. https://doi.org/10.1016/S1470-2045(12)70580-6

Article  PubMed  Google Scholar 

Terwilliger, T., & Abdul-Hay, M. (2017). Acute lymphoblastic leukemia: A comprehensive review and 2017 update. Blood Cancer Journal, 7(6), e577–e577. https://doi.org/10.1038/bcj.2017.53

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun, W., Malvar, J., Sposto, R., Verma, A., Wilkes, J. J., Dennis, R., et al. (2018). Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: A therapeutic advances in childhood leukemia & lymphoma study. Leukemia, 32(11), 2316–2325. https://doi.org/10.1038/s41375-018-0094-0

Article  PubMed  PubMed Central  Google Scholar 

Pui, C. H., Carroll, W. L., Meshinchi, S., & Arceci, R. J. (2011). Biology, risk stratification, and therapy of pediatric acute leukemias: An update. Journal of Clinical Oncology, 29(5), 551–565. https://doi.org/10.1200/jco.2010.30.7405

Article  PubMed  Google Scholar 

Locatelli, F., Zugmaier, G., Rizzari, C., Morris, J. D., Gruhn, B., Klingebiel, T., et al. (2021). Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: A randomized clinical trial. JAMA, 325(9), 843–854. https://doi.org/10.1001/jama.2021.0987

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Brien, M. M., Ji, L., Shah, N. N., Rheingold, S. R., Bhojwani, D., Yuan, C. M., et al. (2022). Phase II trial of inotuzumab ozogamicin in children and adolescents with relapsed or refractory B-cell acute lymphoblastic leukemia: Children’s Oncology Group Protocol AALL1621. Journal of Clinical Oncology, 40(9), 956–967. https://doi.org/10.1200/jco.21.01693

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., et al. (2018). Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. New England Journal of Medicine, 378(5), 439–448. https://doi.org/10.1056/NEJMoa1709866

Article  CAS  PubMed  Google Scholar 

Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., et al. (2011). CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature, 471(7337), 235–239. https://doi.org/10.1038/nature09727

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma, X., Edmonson, M., Yergeau, D., Muzny, D. M., Hampton, O. A., Rusch, M., et al. (2015). Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nature Communications, 6, 6604. https://doi.org/10.1038/ncomms7604

Article  CAS  PubMed  Google Scholar 

Klumper, E., Pieters, R., Veerman, A. J., Huismans, D. R., Loonen, A. H., Hählen, K., et al. (1995). In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood, 86(10), 3861–3868. https://doi.org/10.1182/blood.V86.10.3861.bloodjournal86103861

Article  CAS  PubMed  Google Scholar 

Gottlieb, A. J., Weinberg, V., Ellison, R. R., Henderson, E. S., Terebelo, H., Rafla, S., et al. (1984). Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: A prospective randomized trial by cancer and leukemia group B. Blood, 64(1), 267–274. https://doi.org/10.1182/blood.V64.1.267.267

Article  CAS  PubMed  Google Scholar 

Cooper, S. L., & Brown, P. A. (2015). Treatment of pediatric acute lymphoblastic leukemia. Pediatric Clinics of North America, 62(1), 61–73. https://doi.org/10.1016/j.pcl.2014.09.006

Article  PubMed  Google Scholar 

Silverman, L. B., Stevenson, K. E., O’Brien, J. E., Asselin, B. L., Barr, R. D., Clavell, L., et al. (2010). Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000). Leukemia, 24(2), 320–334. https://doi.org/10.1038/leu.2009.253

Article  CAS  PubMed  Google Scholar 

Pui, C. H., Pei, D., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., et al. (2010). Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia, 24(2), 371–382. https://doi.org/10.1038/leu.2009.252

Article  CAS  PubMed  Google Scholar 

Malempati, S., Gaynon, P. S., Sather, H., La, M. K., & Stork, L. C. (2007). Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children’s Oncology Group study CCG-1952. Journal of Clinical Oncology, 25(36), 5800–5807. https://doi.org/10.1200/jco.2007.10.7508

Article  PubMed  Google Scholar 

Meyer, J. A., Wang, J., Hogan, L. E., Yang, J. J., Dandekar, S., Patel, J. P., et al. (2013). Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nature Genetics, 45(3), 290–294. https://doi.org/10.1038/ng.2558

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jansen, G., Mauritz, R., Drori, S., Sprecher, H., Kathmann, I., Bunni, M., et al. (1998). A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. Journal of Biological Chemistry, 273(46), 30189–30198. https://doi.org/10.1074/jbc.273.46.30189

Article  CAS  PubMed  Google Scholar 

Mosow, J. A. (1998). Methotrexate transport and resistance. Leukemia & Lymphoma, 30(3–4), 215–224. https://doi.org/10.3109/10428199809057535

Article  Google Scholar 

Mudry, R. E., Fortney, J. E., York, T., Hall, B. M., & Gibson, L. F. (2000). Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood, 96(5), 1926–1932. https://doi.org/10.1182/blood.V96.5.1926

Article  CAS  PubMed  Google Scholar 

Yang, J. J., Bhojwani, D., Yang, W., Cai, X., Stocco, G., Crews, K., et al. (2008). Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood, 112(10), 4178–4183. https://doi.org/10.1182/blood-2008-06-165027

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson, D., Skut, P., Hughes, A. M., Ferrari, E., Tickner, J., Xu, J., et al. (2020). The bone marrow microenvironment of pre-B acute lymphoblastic leukemia at single-cell resolution. Scientific Reports, 10(1), 19173. https://doi.org/10.1038/s41598-020-76157-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Méndez-Ferrer, S., Bonnet, D., Steensma, D. P., Hasserjian, R. P., Ghobrial, I. M., Gribben, J. G., et al. (2020). Bone marrow niches in haematological malignancies. Nature Reviews Cancer, 20(5), 285–298. https://doi.org/10.1038/s41568-020-0245-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dander, E., Palmi, C., D'Amico, G., & Cazzaniga, G. (2021). The bone marrow niche in B-cell acute lymphoblastic leukemia: The role of microenvironment from pre-leukemia to overt leukemia. International Journal of Molecular Sciences, 22(9). https://doi.org/10.3390/ijms22094426

Gao, Q., Wang, L., Wang, S., Huang, B., Jing, Y., & Su, J. (2022). Bone marrow mesenchymal stromal cells: Identification, classification, and differentiation. Frontiers in Cell and Developmental Biology, 9, 787118–787118. https://doi.org/10.3389/fcell.2021.787118

Article  PubMed  PubMed Central  Google Scholar 

Li, J.-H., Fan, W.-S., Wang, M.-M., Wang, Y.-H., & Ren, Z.-G. (2018). Effects of mesenchymal stem cells on solid tumor metastasis in experimental cancer models: A systematic review and meta-analysis. Journal of Translational Medicine, 16(1), 113. https://doi.org/10.1186/s12967-018-1484-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramuta, T., & Kreft, M. E. (2022). Mesenchymal stem/stromal cells may decrease success of cancer treatment by inducing resistance to chemotherapy in cancer cells. Cancers 14(15). https://doi.org/10.3390/cancers14153761

Fallati, A., Di Marzo, N., D'Amico, G., & Dander, E. (2022). Mesenchymal stromal cells (MSCs): An ally of B-cell acute lymphoblastic leukemia (B-ALL) cells in disease maintenance and progression within the bone marrow hematopoietic niche. Cancers, 14(14). https://doi.org/10.3390/cancers14143303

Miari, K. E., & Williams, M. T. S. (2023). Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance. British Journal of Pharmacology. https://doi.org/10.1111/bph.16028

Article  PubMed